The company has received the attached notification forms concerning notifiable transactions for close associates of a PDMR. Please refer to the forms for further information.
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
- Flakk Gruppen_Fusjon_Skjema for melding om transaksjoner
- Flakk Invest_Salg_Skjema for melding om transaksjoner
- Flakk Investment_Kjop_Skjema for melding om transaksjoner
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Kvalitena AB (publ) publicerar kvartalsrapport för Q3 202229.11.2022 22:00:00 CET | Pressemelding
Kvalitena publicerar kvartalsrapport för Q3 2022 Bilaga Delårsrapport Q3 2022
Conagen develops high-purity non-GMO sulforaphane by bioconversion29.11.2022 21:23:38 CET | Press release
Commercial production is underway for 2023. Bedford, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Expanding on its portfolio of innovative nutritional products through biotechnology, Conagen, announced the development of its 99% high-purity sulforaphane. Made by a proprietary bioconversion technology, the company plans to begin the commercialization path in 2023. Conagen’s bioconversion methods enable the production of sustainable products from many naturally occurring compounds regardless of rarity or small quantities occurring in nature. “As a supplement product, Conagen’s high-purity sulforaphane is appealing to consumers as the levels found in raw vegetables are too low to realize many of its promising health benefits,” said Casey Lippmeier, Ph.D., senior vice president of innovation. “We’re looking forward to expanding the nutritional market by commercializing sulforaphane in 2023.” Sulforaphane has been associated with supporting health benefits against cancer, diabetes, digestion, a
Yara’s employee share purchase program and mandatory notification of trades29.11.2022 19:02:00 CET | Press release
Oslo, 29 November 2022: The Foundation for employees’ shares in Yara (“Stiftelsen For Ansattes Aksjer i Yara”) has today purchased a total of 34,000 Yara shares (ticker: YAR, ISIN: NO0010208051) in the market at an average price of NOK 463.9398 per share, as part of Yara’s employee share purchase program in Norway. Permanent Yara employees in Norway can take part in the annual offer to buy Yara shares for a value of either NOK 7,500, NOK 15,000 or NOK 30,000. Based on the three alternatives, Yara employees purchased either 16 Yara shares, 32 Yara shares or 64 Yara shares at NOK 466.40 per share. In total, Yara employees purchased 33,264 Yara shares from the Foundation for employees’ shares in Yara. A total of 605 employees participated in the program. Following these transactions, the Foundation for employees’ shares in Yara owns 748 Yara shares. The share purchases linked to the employee share purchase program by the following Yara Board members are considered as PDMR trades under the
Rovio Entertainment Corporation: Repurchase of own shares on 29 November 202229.11.2022 17:45:00 CET | Press release
Rovio Entertainment Oyj STOCK EXCHANGE RELEASE 29.11.2022 at 18.45 EETRovio Entertainment Corporation - Repurchase of own shares on 29.11.2022Rovio Entertainment CorporationIn the Nasdaq HelsinkiDate29.11.2022Exchange transactionBUYShare trading codeROVIOAmount, shares27148Average price/share, EUR5,942434Total cost, EUR161325,20Rovio now holds a total of 6 382 613 shares including the shares repurchased on 29.11.2022On behalf of Rovio Entertainment CorporationOP Corporate Bank PLC Further information: Timo Rahkonen, VP Investor Relations & Corporate Strategy +358 40 730 3442 RovioIR@rovio.com Distribution: Nasdaq Helsinki Ltd Key media www.rovio.com About Rovio: Rovio Entertainment Corporation is a global mobile-first games company that creates, develops and publishes mobile games, which have been downloaded over 5 billion times. Rovio is best known for the global Angry Birds brand, which started as a popular mobile game in 2009, and has since evolved from games to various entertainmen
Ålandsbanken Abp: Återköp av egna aktier 29.11.202229.11.2022 17:30:00 CET | Pressemelding
Ålandsbanken Abp Förändringar i återköpta aktier 29.11.2022 kl. 18:30 EET Ålandsbanken Abp: Återköp av egna aktier 29.11.2022 Datum 29.11.2022 Handelsplats Börsaffär Nasdaq Helsinki Oy (XHEL) Köp Aktie klass ALBBV Antal 346 st. Medelpris/aktie 35,1624 EUR Högsta pris/aktie 35,2000 EUR Lägsta pris/aktie 34,9000 EUR Totalt pris 12 166,19 EUR Ålandsbanken Abp:s innehav av egna aktier 29.11.2022: ALBBV 266 947 st. På Ålandsbanken Abp:s vägnar Skandinaviska Enskilda Banken AB (Publ) Antti Salakka Janne Tiihonen För vidare information vänligen kontakta: Peter Wiklöf, Vd och koncernchef, Ålandsbanken Abp, tfn +358 40 512 7505 Bilaga ALBBV SBB 29112022